These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15793532)

  • 41. Photopheresis and the red man syndrome.
    Knobler R
    Dermatology; 1995; 190(2):97-8. PubMed ID: 7727848
    [No Abstract]   [Full Text] [Related]  

  • 42. Cutaneous T-cell lymphoma. Preface.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():V. PubMed ID: 18405179
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical-scale generation of strongly CD83-expressing dendritic cells using extracorporeal photopheresis.
    Bredberg A; Jonsson S; Lindblom A; Björk P
    Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):113-9. PubMed ID: 17598863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The North American experience with photopheresis.
    Fraser-Andrews EA; Whittaker SJ; Russell-Jones R
    Ther Apher; 1999 Nov; 3(4):347-8. PubMed ID: 10608733
    [No Abstract]   [Full Text] [Related]  

  • 45. Extracorporeal photochemotherapy in the early treatment of cutaneous T-cell lymphoma.
    Fimiani M; Rubegni P; D'Ascenzo G; Andreassi L
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):828-30. PubMed ID: 7929941
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethylene-oxide-induced pruritus associated with extracorporeal photochemotherapy.
    Georgieva J; Steinhoff M; Orfanos CE; Treudler R
    Transfusion; 2004 Oct; 44(10):1532-3. PubMed ID: 15383029
    [No Abstract]   [Full Text] [Related]  

  • 47. Photopheresis for cutaneous T cell lymphoma.
    Heald PW
    Ann N Y Acad Sci; 1991 Dec; 636():171-7. PubMed ID: 1793207
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010].
    Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H1-11. PubMed ID: 21703464
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in understanding the immunobiology and immunotherapy of cutaneous T-cell lymphoma.
    Berger CL; Mariwalla K; Girardi M; Edelson RL
    Adv Dermatol; 2004; 20():217-35. PubMed ID: 15544202
    [No Abstract]   [Full Text] [Related]  

  • 50. Analysis of clinical and serologic predictors of response to extracorporeal photopheresis therapy in cutaneous T-cell lymphoma patients.
    Sun LD; Polly S; Ko JS; Ricci K; Hsi ED; Cooper KD; Fernandez AP
    Photodermatol Photoimmunol Photomed; 2022 Nov; 38(6):600-603. PubMed ID: 35132696
    [No Abstract]   [Full Text] [Related]  

  • 51. Extracorporeal photochemoimmunotherapy in cutaneous T-cell lymphoma.
    Knobler R; Jantschitsch C
    Transfus Apher Sci; 2003 Feb; 28(1):81-9. PubMed ID: 12620272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post-transplant cutaneous T-cell lymphomas.
    Lok C; Viseux V; Denoeux JP; Bagot M
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):137-45. PubMed ID: 16046144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence is lacking for a synergistic or additive effect of combination extracorporeal photopheresis with interferon alfa for cutaneous T-cell lymphoma.
    Zackheim HS
    J Am Acad Dermatol; 2000 Jun; 42(6):1087-8. PubMed ID: 10827420
    [No Abstract]   [Full Text] [Related]  

  • 55. Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma.
    Miller JD; Kirkland EB; Domingo DS; Scull H; Jekutis B; Dallas M; Cooper KD; Baron ED
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):163-71. PubMed ID: 17803594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.
    Duarte RF; Schmitz N; Servitje O; Sureda A
    Bone Marrow Transplant; 2008 Apr; 41(7):597-604. PubMed ID: 18176611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Successful stem cell transplantation in a patient with primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma.
    Wehkamp U; Glaeser D; Oschlies I; Hilgendorf I; Klapper W; Weichenthal M
    Br J Dermatol; 2015 Sep; 173(3):869-71. PubMed ID: 25816848
    [No Abstract]   [Full Text] [Related]  

  • 58. Cutaneous T-cell lymphoma: a model for selective immunotherapy.
    Edelson RL
    Cancer J Sci Am; 1998; 4(2):62-71. PubMed ID: 9532405
    [No Abstract]   [Full Text] [Related]  

  • 59. Extracorporeal photopheresis: the Hellenic experience.
    Dervenoulas J; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):169. PubMed ID: 22361574
    [No Abstract]   [Full Text] [Related]  

  • 60. Pediatric pityriasis lichenoides and cutaneous T-cell lymphoma.
    Lam J; Pope E
    Curr Opin Pediatr; 2007 Aug; 19(4):441-5. PubMed ID: 17630609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.